Mycophenolate mofetil Completed Phase 3 Trials for Heart Transplantation Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02091414A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.